Burns
Volume 34, Issue 8 , Pages 1098-1102, December 2008

Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: A 5-year study, 2000–2004

  • Amen Allah Messadi

      Affiliations

    • Intensive Care Burn Department, Aziza Othmana Hospital, Tunis, Tunisia
  • ,
  • Thabet Lamia

      Affiliations

    • Laboratory for Resistance to Antibiotics, Faculty of Medicine, Tunis, Tunisia
    • Corresponding Author InformationCorresponding author. Tel.: +216 22975018; fax: +216 71389652.
  • ,
  • Bousselmi Kamel

      Affiliations

    • Intensive Care Burn Department, Aziza Othmana Hospital, Tunis, Tunisia
  • ,
  • Oueslati Salima

      Affiliations

    • Intensive Care Burn Department, Aziza Othmana Hospital, Tunis, Tunisia
  • ,
  • Memmi Monia

      Affiliations

    • Intensive Care Burn Department, Aziza Othmana Hospital, Tunis, Tunisia
  • ,
  • Ben Redjeb Saida

      Affiliations

    • Laboratory for Resistance to Antibiotics, Faculty of Medicine, Tunis, Tunisia

Accepted 6 March 2008.

Abstract 

This study aimed to evaluate the relationship between antimicrobial resistance in Pseudomonas aeruginosa and annual antibiotic use in a burn unit.

From 1 January 2000 to 31 December 2004, 203 non-repetitive strains of Ps. aeruginosa were recovered from various clinical specimens. Antimicrobial susceptibility testing was performed using the disc diffusion method, and susceptibility data were interpreted according to break points recommended by the French Society of Microbiology. The antibiotic consumption for imipenem, ceftazidime, cefotaxime, piperacillin-tazobactam, ofloxacin, ciprofloxacin, gentamicin and amikacin was calculated with antimicrobial density. The relationship between antibiotic use and the resistance of Ps. aeruginosa was analysed.

The consumption of ceftazidime and amikacin showed no association with resistance. A statistically significant relationship was observed between increasing use of ciprofloxacin and the incidence of resistant Ps. aeruginosa to this antibiotic (rs=0.89, p=0.05), and a significant correlation between ciprofloxacin consumption and resistance to imipenem was noted (rs=0.89, p=0.043). Restricted use of ciprofloxacin during 2003 and 2004 was followed by a significant decrease of resistance in Ps. aeruginosa. Our report illustrates the major role of ciprofloxacin in the emergence of resistant Ps. aeruginosa.

Keywords: Antibiotic resistance, Antibiotic use, Pseudomonas aeruginosa

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0305-4179(08)00095-8

doi:10.1016/j.burns.2008.03.014

Burns
Volume 34, Issue 8 , Pages 1098-1102, December 2008